July 23, 2014 3:59 AM ET

Biotechnology

Company Overview of Ansaris, Inc.

Company Overview

Ansaris, Inc. provides small molecule drug discovery solutions. It developed CHARRETTE, a virtual fragment-based drug design platform and applied it into an integrated system for drug discovery. The company was founded in 2009 and is based in Blue Bell, Pennsylvania. Ansaris, Inc. operates as a subsidiary of Locus Pharmaceuticals, Inc.

4 Valley Square

512 East Township Line Road

Blue Bell, PA 19422

United States

Founded in 2009

Phone:

215-358-2000

Fax:

215-358-2010

Key Executives for Ansaris, Inc.

Chief Executive Officer
Chief Financial Officer
Age: 48
Head of Discovery Technologies and Senior Director
Vice President of Corporate Development
Controller
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Dermelle, LLC United States
Sertoli Technologies Inc. United States
BEAT BioTherapeutics Corp. United States
RadioRx, Inc. United States
IMI International Medical Innovations, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ansaris, Inc., please visit ansarisbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.